FreeOx Biotech
Business Services · Spain · 1-10 Employees
View Company Info for Free
Overview
Headquarters
C/ Circunval·lació 40 Local Sant Climent...Website
www.freeoxbiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About FreeOx Biotech
FreeOx Biotech is a late-stage clinical company dedicated to the discovery and development of Cerebrovascular Protective Therapeutics. Their most advanced investigational drug, Ox-01, is ready for Phase III trials, while Lip-Ox is a proprietary liposomal formulation technology based on Uric Acid. The company aims to establish strategic partnerships with pharmaceutical companies to advance Ox-01 through clinical validation, registration, and commercialization. Their target clients include pharmaceutical partners and healthcare providers focused on stroke recovery and cerebrovascular health.Explore more
FreeOx Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FreeOx Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if FreeOx Biotech has recently received funding, and reach out quickly before it becomes old news!
Check out if FreeOx Biotech is spiking on competitors!
Product Launch: Get notified when FreeOx Biotech launches new products
Earning: See what the market has to say on FreeOx Biotech recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at FreeOx Biotech
FreeOx Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once FreeOx Biotech has new funding data
Click to see if FreeOx Biotech had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined FreeOx Biotech as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
FreeOx Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
FreeOx Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about FreeOx Biotech.
FreeOx Biotech financials insights
Gather financial insights about FreeOx Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$1.8M
FreeOx Biotech Tech Stack
A closer look at the technologies used by FreeOx Biotech
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Funding
FreeOx Biotech News & Media
FreeOx's Ox-01 to be Evaluated as Adjunct Mechanical Thrombectomy Therapy for Stroke in NINDS-Funded Phase 2/3 Clinical Trial on Stroke-dedicated STEP Platform
FreeOx's Ox-01 Outperforms 3 Candidates from Big Pharma; Phase 2/3 Expected to Initiate in 2025 BARCELONA / PALO ALTO, Spain, Nov. 15, 2024 /PRNewswire-PRWeb/ -- FreeOx Biotech, a clinical stage biopharmaceutical company pioneering the development of a novel drug class for Acute Ischemic...FreeOx Biotech Formally Launches Seed Round to Fund Phase III Pivotal Trial
Planned Phase III for Ox-01 to Begin in AIS in Early 2025 • Pivotal Trial to Evaluate Novel Adjunct Drug for Mechanical Thrombectomy BARCELONA, Spain, Dec. 5, 2023 /PRNewswire-PRWeb/ -- FreeOx Biotech SL, a late-stage clinical biopharmaceutical company pioneering the development of a...FreeOx Biotech lead asset recommended by NIH/NINDS SPAN network for further development
FreeOx Biotech lead asset recommended by NIH/NINDS SPAN network for further development. FreeOx Biotech Adds Leadership for Advancing Ox-01 to Phase III and Commercialization BARCELONA, Spain, Nov. 16, 2023 /PRNewswire-PRWeb/ -- FreeOx Biotech SL, a late-stage clinical biopharmaceutical...FreeOx Closes €500K in Funding
FreeOx Biotech, a Barcelona, Spain-based developer of a new class of neuroprotective drugs, closed its €500k first round of funding. Backers included Montserrat Esteve and Francisco Javier Alsina. Created in 2017 as a spin-out of Hospital Clinic Barcelona-IDIBAPS by Ángel Chamorro, Carlos Lurigados, Ángel Honrado, Tudor G. Jovin and Joan Bigorra, FreeOx Biotech has two […] The post FreeOx Closes €500K in Funding appeared first on FinSMEs.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding FreeOx Biotech
Sign Up For FreeTo access detailed company insights
FreeOx Biotech is a late-stage clinical company dedicated to the discovery and development of Cerebrovascular Protective Therapeutics. Their most advanced investigational drug, Ox-01, is ready for Phase III trials, while Lip-Ox is a proprietary liposomal formulation technology based on Uric Acid. The company aims to establish strategic partnerships... Read More
